Dihexa 'unlimited brain capacity': what the science says

What did @coachcam.peps3 actually say?

The creator describes Dihexa as a compound that "upgrades the entire city" of your brain, contrasting it with stimulants and nootropics that merely optimize existing function. The core claim is that Dihexa amplifies the HGF/c-Met receptor pathway, driving synaptogenesis, dendritic arborization, and long-term potentiation. He also states it was shown to be "10 million times stronger than brain derived neurotrophic factor" in lab studies, while acknowledging human translation is unproven.

To his credit, he repeatedly frames this as educational content, not medical advice, and qualifies the BDNF comparison by saying whether it "translates to 10 million times stronger than actual human brain, that's yet to actually be seen." That caveat matters. But the video's caption, title, and framing around "unlimited brain capacity" and "the limitless pill" do a lot of work that the caveats don't fully undo.

Does the science back this up?

The mechanism is real. The extrapolation to human cognitive enhancement is not yet supported by evidence. Dihexa (PNB-0408, also N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small molecule developed at Washington State University that potentiates HGF signaling at the c-Met receptor. McCoy et al. (2013, Journal of Pharmacology and Experimental Therapeutics) demonstrated that Dihexa reversed cognitive deficits in aged rats and showed synaptogenic activity far exceeding BDNF in cell assays.

The "10 million times stronger" figure comes from in vitro potency comparisons, not from measuring cognitive outcomes in living animals, let alone humans. There are no completed human clinical trials on Dihexa as of this writing. The compound has also shown hepatocyte growth factor-driven activity in cancer biology research, which raises questions about long-term safety that are entirely absent from this video. The mechanisms the creator describes, synaptogenesis, dendritic arborization, long-term potentiation, are accurate neurobiological terms and are plausibly connected to HGF/c-Met signaling. The leap from "plausible mechanism in rats" to "infrastructure builder for your brain" is where this video crosses from education into speculation.

What did they get wrong (or right)?

The creator gets the neuroscience vocabulary right. Synaptogenesis, dendritic arborization, and long-term potentiation are accurately defined, and tying them to HGF/c-Met signaling is consistent with the McCoy et al. research. That's more rigor than most peptide content on TikTok manages.

What they get wrong, or at least seriously underplay, is the evidence gap. Saying the BDNF comparison is "yet to be seen" in humans sounds measured, but it glosses over the fact that there is essentially zero human safety data. HGF is a potent mitogen. Compounds that amplify it systemically have potential oncogenic implications, something explored in cancer literature (Organ and Tsao, 2011, Therapeutic Advances in Medical Oncology). The video presents Dihexa as a tool for skill acquisition and pattern recognition with no discussion of who should not use it, what risks exist, or why it hasn't cleared clinical trials. The "limitless pill" framing in the caption is irresponsible regardless of the in-video disclaimers.

• Correct: HGF/c-Met pathway involvement in neuroplasticity
• Correct: Definition and role of synaptogenesis and LTP
• Misleading: Framing preclinical potency as near-human benefit
• Missing: Any mention of safety, oncogenic risk, or regulatory status

What should you actually know?

Dihexa is a research compound with no approved human use, no published human clinical trials, and a mechanism that warrants caution, not enthusiasm. The preclinical data is genuinely interesting. That's not the same as "it works in humans."

The HGF pathway does more than build synapses. It plays roles in liver regeneration, wound healing, and tumor growth. Compounds that potentiate HGF signaling are not simple cognitive supplements. Organ and Tsao (2011) reviewed c-Met pathway dysregulation as a driver of multiple cancers. That doesn't mean Dihexa causes cancer, but it means the risk profile is unknown and the "just try it" culture around unregulated peptides is especially reckless here.

If you're interested in neuroplasticity support, there are interventions with actual human evidence behind them: aerobic exercise (Erickson et al., 2011, PNAS), sleep optimization, and in some contexts, physician-supervised use of compounds with at least Phase II trial data. Dihexa is not in that category. A telehealth provider who recommends it without acknowledging that gap is not practicing evidence-based medicine.